Showing results (211-220 of 716) with videos related to

Sort By:
Pageof 72
Cancer Chemotherapy and Pharmacology|December 24, 2002
Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemiaYesid Alvarado, Jorge Cortes, Srdan Verstovsek, et al.
Haematologica|September 14, 2014
Dynamics of chronic myeloid leukemia response to dasatinib, nilotinib, and high-dose imatinibAdam Olshen, Min Tang, Jorge Cortes, et al.
Cancer Science|June 19, 2010
Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assaysC Cameron Yin, Jorge Cortes, John Galbincea, et al.
Leukemia Research|September 29, 2007
Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategyIman Jilani, Hagop Kantarjian, Mercedes Gorre, et al.
Leukemia & Lymphoma|August 12, 2014
Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemiaUri Rozovski, Maro Ohanian, Farhad Ravandi, et al.
Leukemia Research|September 3, 2013
Patients with polycythemia vera and essential thrombocythemia with prior malignancy do not have significantly worse outcomeMohamad Cherry, Marylou Cardenas-Turanzas, Hannah Pham, et al.
Blood|October 1, 2005
Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylateElias Jabbour, Hagop Kantarjian, Susan O'Brien, et al.
Mayo Clinic Proceedings|March 11, 2005
Chronic myeloid leukemia: current application of cytogenetics and molecular testing for diagnosis and treatmentAyalew Tefferi, Gordon W Dewald, Mark L Litzow, et al.
Annals of Hematology|November 17, 2017
Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasmsPrajwal Boddu, Lucia Masarova, Srdan Verstovsek, et al.
European Journal of Haematology|December 12, 2017
Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosisLucia Masarova, Ahmad Alhuraiji, Prithviraj Bose, et al.
Pageof 72